lovastatin has been researched along with cetaben in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paoletti, R; Sirtori, CR; Tremoli, E | 1 |
| Kovacs, WJ; Schrader, M; Stangl, H; Walter, I | 1 |
1 review(s) available for lovastatin and cetaben
| Article | Year |
|---|---|
New strategies in the development of anti-atherosclerotic drugs.
Topics: 4-Aminobenzoic Acid; Animals; Arteriosclerosis; Aspirin; Coronary Disease; Fatty Acids, Nonesterified; Hepatomegaly; Humans; Hydrogen Peroxide; Hypolipoproteinemias; Lovastatin; Male; Metformin; Microbodies; Naphthalenes; Oligopeptides; para-Aminobenzoates; Platelet Aggregation; Rats | 1980 |
1 other study(ies) available for lovastatin and cetaben
| Article | Year |
|---|---|
The hypolipidemic compound cetaben induces changes in Golgi morphology and vesicle movement.
Topics: 4-Aminobenzoic Acid; Animals; Anticholesteremic Agents; Blotting, Northern; Cells, Cultured; Cholesterol; Cytoplasmic Vesicles; Cytoskeleton; Electrons; Enzyme Precursors; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Golgi Apparatus; Homeostasis; Humans; Hypolipidemic Agents; Immunoblotting; Kinetics; Lectins; Lipids; Lovastatin; Microscopy, Electron; Microtubules; para-Aminobenzoates; Rats | 2004 |